HAIA
HAIA
Healthcare AI Acquisition Corp.Income Statement
| Period | Revenue | Operating Expense | Net Income | Net Profit Margin | Earnings Per Share | EBITDA |
|---|---|---|---|---|---|---|
| Q2-2025 | $0 | $0 ▼ | $-542.06K ▼ | 0% | $-0.1 ▼ | $0 ▲ |
| Q1-2025 | $0 | $75.83K ▼ | $-74.12K ▼ | 0% | $-0.01 ▼ | $-75.83K ▲ |
| Q4-2024 | $0 | $99.49K ▼ | $385.56K ▲ | 0% | $0.07 ▲ | $-99.49K ▲ |
| Q3-2024 | $0 | $413.04K ▲ | $-7.66K ▼ | 0% | $-0 ▼ | $-413.04K ▼ |
| Q2-2024 | $0 | $70.75K | $145.66K | 0% | $0.02 | $-70.75K |
What's going well?
Share count decreased, so existing shareholders aren't being diluted. No debt or interest expenses means the company isn't burdened by loans.
What's concerning?
HAIA has no revenue and its losses have grown dramatically. The company is burning cash with no sign of sales or a working business model.
Balance Statement
| Period | Cash & Short-term | Total Assets | Total Liabilities | Total Equity |
|---|---|---|---|---|
| Q2-2025 | $212 | $2.86M ▼ | $3.16M ▲ | $-2.17M ▼ |
| Q1-2025 | $212 | $5.75M ▲ | $2.56M ▲ | $3.19M ▼ |
| Q4-2024 | $212 | $5.66M ▼ | $2.39M ▲ | $3.26M ▼ |
| Q3-2024 | $212 | $6.85M ▲ | $1.73M ▲ | $5.11M ▼ |
| Q2-2024 | $212 | $6.79M | $1.67M | $5.12M |
What's financially strong about this company?
The company eliminated all debt this quarter, so there are no loan payments due. There are no hidden or unusual liabilities.
What are the financial risks or weaknesses?
Shareholder equity is deeply negative, meaning the company owes far more than it owns. Cash is almost nonexistent, and current liabilities are much higher than current assets, putting the company at risk of running out of money.
Cash Flow Statement
| Period | Net Income | Cash From Operations | Cash From Investing | Cash From Financing | Net Change | Free Cash Flow |
|---|---|---|---|---|---|---|
| Q4-2024 | $385.56K ▲ | $-122.7K ▲ | $0 | $122.7K ▼ | $0 | $-122.7K ▲ |
| Q3-2024 | $-7.66K ▼ | $-323.43K ▼ | $0 | $323.43K ▲ | $0 | $-323.43K ▼ |
| Q2-2024 | $145.66K ▲ | $0 | $0 | $0 | $0 | $0 |
| Q1-2024 | $-466.72K ▼ | $0 ▼ | $0 | $0 | $0 | $0 ▼ |
| Q4-2023 | $303.78K | $411.84K | $0 | $0 | $0 | $411.84K |
What's strong about this company's cash flow?
Cash burn is shrinking quarter over quarter, so losses are narrowing. No dilution from new shares or stock compensation.
What are the cash flow concerns?
Business is not generating cash and needs to borrow every quarter just to survive. Cash on hand is almost zero, and working capital is now draining cash.
5-Year Trend Analysis
A comprehensive look at Healthcare AI Acquisition Corp.'s financial evolution and strategic trajectory over the past five years.
Historically, HAIA benefited from a large upfront capital pool and generated non‑operating income that supported positive net results in its early years. It still has positive shareholders’ equity, relatively limited long‑term debt, and a lean cost structure consistent with a SPAC. Strategically, it has a signed business combination agreement with a concrete target in an area—digital insurance brokerage—where technology can be a meaningful differentiator, and it offers that target access to U.S. public markets and potential capital.
The most pressing risks are financial and execution‑related. HAIA has no operating revenue, persistent negative operating and free cash flow, and a sharply reduced cash position, alongside rising short‑term obligations and deteriorated liquidity ratios. Profitability has collapsed as non‑operating income faded, and the balance sheet no longer carries the same cushion it once did. On top of this, there is deal risk around closing the Leading Group transaction within the extended timeframe, as well as longer‑term regulatory, competitive, and geopolitical risks associated with operating a digital insurance platform in China and maintaining a cross‑border listed structure.
Looking ahead, the company’s trajectory is binary and highly contingent on the completion and success of the proposed merger. If the transaction closes and sufficient capital is raised or retained, HAIA will effectively transform into a Chinese insurtech broker, with a completely different financial and competitive profile from the shell company reflected in current statements. If the deal is delayed, altered, or fails, the existing trends—no revenue, negative cash flows, shrinking assets, and liquidity strain—suggest that the current structure has limited runway. Any forward view therefore depends more on deal execution and the quality of the target business than on HAIA’s past financial performance, which mainly documents the gradual rundown of a SPAC’s initial capital base.
About Healthcare AI Acquisition Corp.
Healthcare AI Acquisition Corp. does not have significant operations. The company focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses or entities.
Income Statement
| Period | Revenue | Operating Expense | Net Income | Net Profit Margin | Earnings Per Share | EBITDA |
|---|---|---|---|---|---|---|
| Q2-2025 | $0 | $0 ▼ | $-542.06K ▼ | 0% | $-0.1 ▼ | $0 ▲ |
| Q1-2025 | $0 | $75.83K ▼ | $-74.12K ▼ | 0% | $-0.01 ▼ | $-75.83K ▲ |
| Q4-2024 | $0 | $99.49K ▼ | $385.56K ▲ | 0% | $0.07 ▲ | $-99.49K ▲ |
| Q3-2024 | $0 | $413.04K ▲ | $-7.66K ▼ | 0% | $-0 ▼ | $-413.04K ▼ |
| Q2-2024 | $0 | $70.75K | $145.66K | 0% | $0.02 | $-70.75K |
What's going well?
Share count decreased, so existing shareholders aren't being diluted. No debt or interest expenses means the company isn't burdened by loans.
What's concerning?
HAIA has no revenue and its losses have grown dramatically. The company is burning cash with no sign of sales or a working business model.
Balance Statement
| Period | Cash & Short-term | Total Assets | Total Liabilities | Total Equity |
|---|---|---|---|---|
| Q2-2025 | $212 | $2.86M ▼ | $3.16M ▲ | $-2.17M ▼ |
| Q1-2025 | $212 | $5.75M ▲ | $2.56M ▲ | $3.19M ▼ |
| Q4-2024 | $212 | $5.66M ▼ | $2.39M ▲ | $3.26M ▼ |
| Q3-2024 | $212 | $6.85M ▲ | $1.73M ▲ | $5.11M ▼ |
| Q2-2024 | $212 | $6.79M | $1.67M | $5.12M |
What's financially strong about this company?
The company eliminated all debt this quarter, so there are no loan payments due. There are no hidden or unusual liabilities.
What are the financial risks or weaknesses?
Shareholder equity is deeply negative, meaning the company owes far more than it owns. Cash is almost nonexistent, and current liabilities are much higher than current assets, putting the company at risk of running out of money.
Cash Flow Statement
| Period | Net Income | Cash From Operations | Cash From Investing | Cash From Financing | Net Change | Free Cash Flow |
|---|---|---|---|---|---|---|
| Q4-2024 | $385.56K ▲ | $-122.7K ▲ | $0 | $122.7K ▼ | $0 | $-122.7K ▲ |
| Q3-2024 | $-7.66K ▼ | $-323.43K ▼ | $0 | $323.43K ▲ | $0 | $-323.43K ▼ |
| Q2-2024 | $145.66K ▲ | $0 | $0 | $0 | $0 | $0 |
| Q1-2024 | $-466.72K ▼ | $0 ▼ | $0 | $0 | $0 | $0 ▼ |
| Q4-2023 | $303.78K | $411.84K | $0 | $0 | $0 | $411.84K |
What's strong about this company's cash flow?
Cash burn is shrinking quarter over quarter, so losses are narrowing. No dilution from new shares or stock compensation.
What are the cash flow concerns?
Business is not generating cash and needs to borrow every quarter just to survive. Cash on hand is almost zero, and working capital is now draining cash.
5-Year Trend Analysis
A comprehensive look at Healthcare AI Acquisition Corp.'s financial evolution and strategic trajectory over the past five years.
Historically, HAIA benefited from a large upfront capital pool and generated non‑operating income that supported positive net results in its early years. It still has positive shareholders’ equity, relatively limited long‑term debt, and a lean cost structure consistent with a SPAC. Strategically, it has a signed business combination agreement with a concrete target in an area—digital insurance brokerage—where technology can be a meaningful differentiator, and it offers that target access to U.S. public markets and potential capital.
The most pressing risks are financial and execution‑related. HAIA has no operating revenue, persistent negative operating and free cash flow, and a sharply reduced cash position, alongside rising short‑term obligations and deteriorated liquidity ratios. Profitability has collapsed as non‑operating income faded, and the balance sheet no longer carries the same cushion it once did. On top of this, there is deal risk around closing the Leading Group transaction within the extended timeframe, as well as longer‑term regulatory, competitive, and geopolitical risks associated with operating a digital insurance platform in China and maintaining a cross‑border listed structure.
Looking ahead, the company’s trajectory is binary and highly contingent on the completion and success of the proposed merger. If the transaction closes and sufficient capital is raised or retained, HAIA will effectively transform into a Chinese insurtech broker, with a completely different financial and competitive profile from the shell company reflected in current statements. If the deal is delayed, altered, or fails, the existing trends—no revenue, negative cash flows, shrinking assets, and liquidity strain—suggest that the current structure has limited runway. Any forward view therefore depends more on deal execution and the quality of the target business than on HAIA’s past financial performance, which mainly documents the gradual rundown of a SPAC’s initial capital base.

CEO
Jiande Chen

